Clik here to view.
China to monitor the anti-diabetes drug Avandia
Chinese health officials announced that they will closely monitor any issues and concerns about the anti-diabetes drug Avandia. After the rise of relative concerns about the use of the drug in the U.S....
View ArticleClik here to view.
Glaxo to Face a $3.4 B Settlement on Avandia Lawsuit
Reports said Monday that GlaxoSmithKline is bound to face a multi-district litigation amounting to an estimated $3.4 billion against its anti-diabetes drug, Avandia. According to the reports, a number...
View ArticleClik here to view.
GlaxoSmithKline Whistleblower: False-Claims Lawsuit Involving Popular Drugs...
Three months ago, pharmaceutical maker GlaxoSmithKline agreed to pay $750 million to resolve a U.S. government false-claims lawsuit over charges that the company knowingly manufactured and sold...
View ArticleClik here to view.
FDA Updates Info Guide on Avandia Side Effects
(February 10, 2011) (Courtesy Photo) U.S. Food and Drug Administration (FDA) announced Thursday that updated information of Avandia side effects has been added to physician labeling and patient...
View ArticleClik here to view.
GSK Posts Q4 Loss after Avandia Settlement
(London, UK – February 10, 2011) (Courtesy Photo) GlaxoSmithKline (GSK) posted Thursday a net loss of 690 million pounds ($1.12 billion) after taking a 2.2 billion pound charge for the Avandia...
View Article
